Human Induced Pluripotent Stem Cells as a Disease Model System for Heart Failure

Area of Science:

• Cardiovascular Research
• Stem Cell Biology
• Translational Medicine

Background:

• Heart failure is a prevalent condition with high morbidity and mortality.
• Current therapeutic approaches face translational hurdles due to a lack of effective disease models.
• Diverse etiologies contribute to heart failure, including genetic, infectious, and toxic factors.

Purpose of the Study:

• To review the application of human induced pluripotent stem cells (hiPSCs) in modeling heart failure.
• To highlight the potential of hiPSC-derived cardiomyocytes (hiPSC-CMs) in advancing cardiovascular research.
• To discuss the progress and limitations of hiPSC-CMs as a model system for heart failure.

Main Methods:

• Utilizing human induced pluripotent stem cells (hiPSCs) for disease modeling.
• Differentiating hiPSCs into cardiomyocytes (hiPSC-CMs) to create patient-specific models.
• Employing advanced techniques such as 3D cultures and high-throughput screening.

Main Results:

• hiPSC-CMs enable the recapitulation of cardiac diseases in vitro, facilitating mechanistic studies.
• Significant advancements have been made in hiPSC-CM yield, maturity, and in vivo resemblance.
• hiPSC-CMs are increasingly used to elucidate molecular mechanisms and test novel therapeutic strategies for heart failure.

Conclusions:

• hiPSC-CMs represent an essential and evolving model system in cardiovascular research.
• Despite remaining immaturity and limitations in recapitulating in vivo complexity, hiPSC-CMs hold immense promise for heart failure research.
• Continued improvements in differentiation protocols and assays will further enhance the utility of hiPSC-CMs.